Literature DB >> 9663557

A role for natural killer cells in the immunopathogenesis of multiple sclerosis.

L F Kastrukoff1, N G Morgan, D Zecchini, R White, A J Petkau, J Satoh, D W Paty.   

Abstract

Seventeen relapsing-remitting (R/R) multiple sclerosis (MS) patients and age/sex matched controls were studied every 6 weeks for 2 years. Disease activity, determined both clinically and by serial MRI, was correlated with natural killer (NK) cell functional activity (FA) and phenotype. Mean NK cell FA is significantly lower in MS patients, compared to controls (P < 0.001), while variability around the means is significantly greater (P < 0.01). The spectrum of mean NK cell FA, observed in the patient cohort, along with cyclical nature of the FA and phenotype over time, observed in both patients and controls, may begin to explain the discrepant results reported in previous studies. In R/R MS, there is a significant correlation between reductions (valleys) in NK cell FA and the development of active lesions on MRI, new (P < 0.001) or enlarging (P = 0.05). More importantly, a significant number of active lesions, new (P = 0.01) and enlarging (P = 0.02), are preceded by a reduction in NK cell FA. The correlation between the onset of clinical attacks and valleys of NK cell FA is also significant (P = 0.002). When taken together, the results suggest that reductions (valleys) in NK cell FA represent periods of susceptibility for the development of active lesions on MRI and clinical attacks. A significant positive correlation is also identified between mean NK cell FA for each R/R MS patient and total number of active MRI lesions developed by that patient over the 2 years (P = 0.001). The results would suggest that R/R MS patients with a higher mean NK cell FA are at greater risk for the development of active lesions. These results support the proposal that NK cells may play a role in the immunopathogenesis of R/R MS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663557     DOI: 10.1016/s0165-5728(98)00014-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  30 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRalpha/beta+CD3+CD4-CD8- double-negative T cells.

Authors:  S Yeh; Z Li; H N Sen; W-K Lim; F Gill; K Perkins; V K Rao; R B Nussenblatt
Journal:  Br J Ophthalmol       Date:  2010-06       Impact factor: 4.638

Review 3.  The role of natural killer cells in curbing neuroinflammation.

Authors:  Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2007-09-29       Impact factor: 3.478

Review 4.  Role of the innate immune system in the pathogenesis of multiple sclerosis.

Authors:  Roopali Gandhi; Alice Laroni; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2010-04-15       Impact factor: 3.478

Review 5.  Multiple sclerosis and the role of immune cells.

Authors:  Rune A Høglund; Azzam A Maghazachi
Journal:  World J Exp Med       Date:  2014-08-20

6.  CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.

Authors:  Laura Hertwig; Isabell Hamann; Silvina Romero-Suarez; Jason M Millward; Rebekka Pietrek; Coralie Chanvillard; Hanna Stuis; Karolin Pollok; Richard M Ransohoff; Astrid E Cardona; Carmen Infante-Duarte
Journal:  Eur J Immunol       Date:  2016-07-14       Impact factor: 5.532

Review 7.  Daclizumab therapy for multiple sclerosis.

Authors:  Bibiana Bielekova
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

8.  KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.

Authors:  P P Banerjee; L Pang; S S Soldan; S M Miah; A Eisenberg; S Maru; A Waldman; E A Smith; Y Rosenberg-Hasson; D Hirschberg; A Smith; D V Ablashi; K S Campbell; J S Orange
Journal:  Mol Immunol       Date:  2018-11-24       Impact factor: 4.407

Review 9.  Regulatory NK-cell functions in inflammation and autoimmunity.

Authors:  Anna Lünemann; Jan D Lünemann; Christian Münz
Journal:  Mol Med       Date:  2009-05-11       Impact factor: 6.354

10.  Altered gene expression and function of peripheral blood natural killer cells in children with autism.

Authors:  Amanda M Enstrom; Lisa Lit; Charity E Onore; Jeff P Gregg; Robin L Hansen; Isaac N Pessah; Irva Hertz-Picciotto; Judy A Van de Water; Frank R Sharp; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2008-08-14       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.